Procter & Gamble Hygiene & Health Care Ltd.
NSE: PGHH · Personal Care
Snapshot
Unlock Procter & Gamble Hygiene & Health Care Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Procter & Gamble Hygiene and Health Care Limited is a prominent Indian FMCG company specialising in feminine care and healthcare products. Its portfolio includes well-known brands such as Whisper, Vicks, and Pampers, distributed through a diverse network of retail channels.
Business Model
The company generates revenue by manufacturing and marketing branded consumer goods across the feminine hygiene and healthcare segments. It leverages a wide distribution network, including mass merchandisers, grocery stores, and drugstores, to reach consumers across India.
- Incorporation Year:1964
Growth Outlook
Growth is driven by the strong brand equity of its core product lines and the continued expansion of its retail footprint in the Indian market. The company focuses on maintaining its market leadership through consistent product innovation and consumer engagement.
Key Risks
- Input Cost Volatility. Fluctuations in the prices of raw materials and packaging commodities can significantly impact operating margins.
- Intense Market Competition. The FMCG sector in India is highly competitive, with both domestic and multinational players vying for market share through aggressive pricing and marketing.
- Regulatory and Compliance Risks. Changes in healthcare regulations or consumer safety standards for hygiene products could necessitate costly product reformulations or operational adjustments.
- Supply Chain Disruptions. Dependence on complex global and local supply chains makes the company vulnerable to logistical bottlenecks and distribution inefficiencies.
Start your research today
Unlock AI insights, financials, peers and live data on Procter & Gamble Hygiene & Health Care Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,245 Cr
TTM · standalone
NET PROFIT
₹791 Cr
TTM · standalone
EPS
₹243.59
TTM · standalone
RETURN ON EQUITY
106.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
125.6%
TTM · standalone
P/E
31.5x
Q1 FY27 · standalone
EV/EBITDA
21.7x
Q1 FY27 · standalone
EBITDA MARGIN
26.4%
TTM · standalone
NET PROFIT MARGIN
14.2%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Personal Care
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Procter & Gamble Hygiene & Health Care Ltd.PGHH | ₹24,889 Cr | 31.48 | 21.74 | 25.6% | 26.4% | 106.1% | 125.6% | -43.3% |
Cupid LimitedCUPID | ₹38,074 Cr | 104.10 | 198.43 | — | 42.3% | 34.6% | 45.3% | +58.2% |
Gillette India Ltd.GILLETTE | ₹23,828 Cr | 35.67 | 23.87 | 38.3% | 31.1% | 67.8% | 83.2% | -30.7% |
Emami Ltd.EMAMILTD | ₹15,978 Cr | 21.34 | 15.06 | 2.8% | 27.0% | 26.7% | 30.3% | -40.5% |
Honasa Consumer Ltd.HONASA | ₹15,357 Cr | 61.66 | 39.81 | 21.1% | 15.0% | 19.2% | 23.6% | +55.9% |
Bajaj Consumer Care LimitedBAJAJCON | ₹6,760 Cr | 30.99 | 23.14 | 25.8% | 23.5% | 29.7% | 36.0% | +122.2% |
As of Q1 FY27
Financials
Procter & Gamble Hygiene & Health Care Ltd.
NSE: PGHH · Personal Care
Snapshot
Unlock Procter & Gamble Hygiene & Health Care Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Procter & Gamble Hygiene and Health Care Limited is a prominent Indian FMCG company specialising in feminine care and healthcare products. Its portfolio includes well-known brands such as Whisper, Vicks, and Pampers, distributed through a diverse network of retail channels.
Business Model
The company generates revenue by manufacturing and marketing branded consumer goods across the feminine hygiene and healthcare segments. It leverages a wide distribution network, including mass merchandisers, grocery stores, and drugstores, to reach consumers across India.
- Incorporation Year:1964
Growth Outlook
Growth is driven by the strong brand equity of its core product lines and the continued expansion of its retail footprint in the Indian market. The company focuses on maintaining its market leadership through consistent product innovation and consumer engagement.
Key Risks
- Input Cost Volatility. Fluctuations in the prices of raw materials and packaging commodities can significantly impact operating margins.
- Intense Market Competition. The FMCG sector in India is highly competitive, with both domestic and multinational players vying for market share through aggressive pricing and marketing.
- Regulatory and Compliance Risks. Changes in healthcare regulations or consumer safety standards for hygiene products could necessitate costly product reformulations or operational adjustments.
- Supply Chain Disruptions. Dependence on complex global and local supply chains makes the company vulnerable to logistical bottlenecks and distribution inefficiencies.
Start your research today
Unlock AI insights, financials, peers and live data on Procter & Gamble Hygiene & Health Care Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,245 Cr
TTM · standalone
NET PROFIT
₹791 Cr
TTM · standalone
EPS
₹243.59
TTM · standalone
RETURN ON EQUITY
106.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
125.6%
TTM · standalone
P/E
31.5x
Q1 FY27 · standalone
EV/EBITDA
21.7x
Q1 FY27 · standalone
EBITDA MARGIN
26.4%
TTM · standalone
NET PROFIT MARGIN
14.2%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Personal Care
As of Q1 FY27